MARKET

SER

SER

Serina Therapeutics
AMEX
1.510
-0.130
-7.93%
Pre Market: 1.535 +0.025 +1.63% 04:09 05/19 EDT
OPEN
1.620
PREV CLOSE
1.640
HIGH
1.640
LOW
1.510
VOLUME
4
TURNOVER
0
52 WEEK HIGH
7.92
52 WEEK LOW
1.220
MARKET CAP
22.65M
P/E (TTM)
-0.7640
1D
5D
1M
3M
1Y
5Y
1D
Serina Therapeutics (SER) Gets a Buy from JonesTrading
TipRanks · 18h ago
Weekly Report: what happened at SER last week (0511-0515)?
Weekly Report · 1d ago
Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks
TipRanks · 3d ago
Serina Therapeutics Says Phase 1b Registrational Clinical Study of SER-252 Underway In Advanced Parkinson's Disease; TFL Data From The SAD Study Arm Targeted For First Half of 2027
Benzinga · 4d ago
Serina Therapeutics Q1 EPS $(0.58) Misses $(0.44) Estimate
Benzinga · 4d ago
Serina Therapeutics GAAP EPS of -$0.58 misses by $0.14
Seeking Alpha · 4d ago
*Serina Therapeutics 1Q Loss/Shr 58c >SER
Dow Jones · 4d ago
Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
Barchart · 4d ago
More
About SER
Serina Therapeutics Inc. is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. The Company's POZ Platform provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Its proprietary POZ technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Its POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. SER-252 is the Company’s lead candidate for advanced Parkinson’s disease. SER-252 is an investigational apomorphine therapy developed with its POZ platform and designed to provide continuous dopaminergic stimulation.

Webull offers Serina Therapeutics Inc stock information, including AMEX: SER real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SER stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SER stock methods without spending real money on the virtual paper trading platform.